Log in to save to my catalogue

Ca 2+ -Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-c...

Ca 2+ -Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-c...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32193379

Ca 2+ -Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids

About this item

Full title

Ca 2+ -Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids

Publisher

England

Journal title

Nature communications, 2020-03, Vol.11 (1), p.1455

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

The lipopeptide daptomycin is used as an antibiotic to treat severe infections with gram-positive pathogens, such as methicillin resistant Staphylococcus aureus (MRSA) and drug-resistant enterococci. Its precise mechanism of action is incompletely understood, and a specific molecular target has not been identified. Here we show that Ca
-daptomyc...

Alternative Titles

Full title

Ca 2+ -Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_32193379

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_32193379

Other Identifiers

E-ISSN

2041-1723

DOI

10.1038/s41467-020-15257-1

How to access this item